# Efficacy and Tolerability of Atomoxetine (Strattera) in Adult Patients With Generalized Social Anxiety Disorder

> **NCT00260533** · PHASE2,PHASE3 · COMPLETED · sponsor: **University of California, San Diego** · enrollment: 27 (actual)

## Conditions studied

- Generalized Social Phobia

## Interventions

- **DRUG:** atomoxetine
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT00260533
- **Lead sponsor:** University of California, San Diego
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-11
- **Primary completion:** 2008-07
- **Final completion:** 2008-07
- **Target enrollment:** 27 (ACTUAL)
- **Last updated:** 2016-06-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00260533

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00260533, "Efficacy and Tolerability of Atomoxetine (Strattera) in Adult Patients With Generalized Social Anxiety Disorder". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00260533. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*